| The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms JD Khoury, E Solary, O Abla, Y Akkari, R Alaggio, JF Apperley, R Bejar, ... leukemia 36 (7), 1703-1719, 2022 | 2841 | 2022 |
| The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms R Alaggio, C Amador, I Anagnostopoulos, AD Attygalle, IBO Araujo, ... Leukemia 36 (7), 1720-1748, 2022 | 2559 | 2022 |
| CD19 CAR–T cells of defined CD4+:CD8+ composition in adult B cell ALL patients CJ Turtle, LA Hanafi, C Berger, TA Gooley, S Cherian, M Hudecek, ... The Journal of clinical investigation 126 (6), 2123-2138, 2016 | 2292 | 2016 |
| Blinatumomab versus chemotherapy for advanced acute lymphoblastic leukemia H Kantarjian, A Stein, N Gökbuget, AK Fielding, AC Schuh, JM Ribera, ... New England Journal of Medicine 376 (9), 836-847, 2017 | 2058 | 2017 |
| The genetic basis of early T-cell precursor acute lymphoblastic leukaemia J Zhang, L Ding, L Holmfeldt, G Wu, SL Heatley, D Payne-Turner, ... Nature 481 (7380), 157-163, 2012 | 1866 | 2012 |
| Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party GJ Schuurhuis, M Heuser, S Freeman, MC Béné, F Buccisano, J Cloos, ... Blood, The Journal of the American Society of Hematology 131 (12), 1275-1291, 2018 | 1144 | 2018 |
| Immunotherapy of non-Hodgkin’s lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor–modified T cells CJ Turtle, LA Hanafi, C Berger, M Hudecek, B Pender, E Robinson, ... Science translational medicine 8 (355), 355ra116-355ra116, 2016 | 1122 | 2016 |
| Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies CC Pritchard, E Kroh, B Wood, JD Arroyo, KJ Dougherty, MM Miyaji, ... Cancer prevention research 5 (3), 492-497, 2012 | 1020 | 2012 |
| Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist WC Liles, HE Broxmeyer, E Rodger, B Wood, K Hübel, S Cooper, ... Blood 102 (8), 2728-2730, 2003 | 932 | 2003 |
| The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia Y Liu, J Easton, Y Shao, J Maciaszek, Z Wang, MR Wilkinson, ... Nature genetics 49 (8), 1211-1218, 2017 | 924 | 2017 |
| Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells BG Till, MC Jensen, J Wang, EY Chen, BL Wood, HA Greisman, X Qian, ... Blood, The Journal of the American Society of Hematology 112 (6), 2261-2271, 2008 | 906 | 2008 |
| The genomic landscape of hypodiploid acute lymphoblastic leukemia L Holmfeldt, L Wei, E Diaz-Flores, M Walsh, J Zhang, L Ding, ... Nature genetics 45 (3), 242-252, 2013 | 830 | 2013 |
| Durable molecular remissions in chronic lymphocytic leukemia treated with CD19-specific chimeric antigen receptor–modified T cells after failure of ibrutinib CJ Turtle, KA Hay, LA Hanafi, D Li, S Cherian, X Chen, B Wood, ... Journal of Clinical Oncology 35 (26), 3010-3020, 2017 | 729 | 2017 |
| Using synthetic templates to design an unbiased multiplex PCR assay CS Carlson, RO Emerson, AM Sherwood, C Desmarais, MW Chung, ... Nature communications 4 (1), 2680, 2013 | 628 | 2013 |
| Unmetabolized folic acid in plasma is associated with reduced natural killer cell cytotoxicity among postmenopausal women AM Troen, B Mitchell, B Sorensen, MH Wener, A Johnston, B Wood, ... The Journal of nutrition 136 (1), 189-194, 2006 | 614 | 2006 |
| PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia Z Gu, ML Churchman, KG Roberts, I Moore, X Zhou, J Nakitandwe, ... Nature genetics 51 (2), 296-307, 2019 | 551 | 2019 |
| Association of minimal residual disease with clinical outcome in pediatric and adult acute lymphoblastic leukemia: a meta-analysis DA Berry, S Zhou, H Higley, L Mukundan, S Fu, GH Reaman, BL Wood, ... JAMA oncology 3 (7), e170580-e170580, 2017 | 543 | 2017 |
| Increased erythrocyte phosphatidylserine exposure in sickle cell disease: flow-cytometric measurement and clinical associations BL Wood, DF Gibson, JF Tait | 535 | 1996 |
| Identification of a human heme exporter that is essential for erythropoiesis JG Quigley, Z Yang, MT Worthington, JD Phillips, KM Sabo, DE Sabath, ... Cell 118 (6), 757-766, 2004 | 517 | 2004 |
| 2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party M Heuser, SD Freeman, GJ Ossenkoppele, F Buccisano, CS Hourigan, ... Blood, The Journal of the American Society of Hematology 138 (26), 2753-2767, 2021 | 508 | 2021 |
